Skip to main content
RLAY logo
RLAY
(NASDAQ)
Relay Therapeutics, Inc.
$17.44-- (--)
Loading... - Market loading

Relay Therapeutics (RLAY) Stock Price & Financial Analysis

Relay Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.65 - $17.70
52-Week High$17.70
52-Week Low$3.03
Open$16.65
Volume2.62M
Average Volume (3M)4.54M
Market Cap3.14B
Shares Outstanding179.85M
Price to Sales (P/S)293.77
Price to Book (P/B)4.88
EV/EBITDA-10.84
Revenue (TTM)10.68M
Net Income (TTM)-272.70M
Free Cash Flow (TTM)-213.38M
EPS (TTM)$-1.57
Profit Margin-2554.14%
Operating Margin-2776.61%
Return on Equity (ROE)-42.47%
Debt to Equity0.05
50-Day MA$14.27
200-Day MA$9.44
52-Week Change439.94%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Relay Therapeutics

What is the current stock price for RLAY?

As of the latest trading session, RLAY stock trades at $17.44. The 52-week range is $3.03–$17.70, with a day range of $16.64–$17.70.

What is the P/E ratio for RLAY?

The P/E ratio (Price-to-Earnings) for RLAY is shown in the Key Statistics section. This valuation metric helps compare Relay Therapeutics, Inc. to industry peers.

Does RLAY pay dividends?

Relay Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RLAY?

Based on 13 analysts, the consensus for RLAY is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of RLAY?

Relay Therapeutics's market capitalization is $3.14B, classifying it as a mid-cap company. Relay Therapeutics operates in the Healthcare sector within the Biotechnology industry.